NEW YORK (GenomeWeb News) — Cepheid has paid Idaho Technology $3.5 million and penned a cross-licensing agreement to settle a patent-infringement suit, Cepheid said today.
Terms of the settlement call for the companies to pay license fees and enable them to “continue to make and sell their respective lines for products.
Idaho Technology sued Cephied in 2005 for allegedly infringing three patents that cover "rapid polymerase chain reaction methods and instrumentation, use of SYBR Green I in PCR reactions, and certain methods of analysis of real-time PCR data,” Cepheid said.
Cepheid said the settlement “resolves all claims” made by Idaho Tech and its licensor, University of Utah Research Foundation, and resulted in a dismissal of the case.
Idaho Technology, based in Salt Lake City, makes instruments for pathogen detection, reagents, and thermocyclers.